Low lean mass associated with weakness was established by applying criteria from the Foundation for the National Institutes of Health to measurements of appendicular lean mass from DXA scans
No history of absorption issues
Patient Testimonials See what the Klinic community is saying Deborah Allen How Klinic's Metabolic Health Program Works Get matched with a licensed provider Fill our a short form and we will verify your insurance and match you with the right provider Complete an online visit Answer questions about your weight loss goals, medical history, and current medications and our provider will create a personalized treatment plan for you Medication shipped to you and Prior Authorization Support In case medication is prescribed, we will handle the prior authorization process with your insurer and you will get medication delivered to your door, with ongoing provider support
Patient selection for the 10mg dose should encompass glycemic status and prior response to 5mg, weight loss targets, renal function, cardiovascular risk profile, retinopathy status, history of pancreatitis or gallbladder disease, and the patients experience of gastrointestinal adverse reactions during prior escalation steps
The SURMOUNT-1 clinical trial, published in the New England Journal of Medicine, demonstrated average body weight reductions of up to 20.9 percent over 72 weeks among participants taking Tirzepatide
